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Целта на ова истражување беше да изврши проценка на централната дебелина, која е основ-
на карактеристика на Кушинговиот синдром (КС), со апсорпциометрија со двојно-енергетски 
х-зраци и да се одредат индекси кои прецизно ги диференцираат КС од не-КС задебелените 
жени. Кај 12 жени со КС и 12 контролни здебелени жени (КД) со соодветен ИТМ како и кај 12 кон-
тролни здрави жени (К) со нормален ИТМ  беа испитувани ДХА параметрите: регионална (труп, 
раце и нозе), ткивна (ТМ) и масна маса (ММ), како и дијагностичката точност (ДТ) на пресечните 
точки (ПТ) на нивните количници. Најдобра диференцираност на КС од К обезбеди ПТ од 0,24 
за андроид/нозе ТМ количникот со ДТ од 100%, додека ПТ на количникот нозе/труп ТМ (0,67) 
имаше ДТ од 95,83%. Андроид/нозе ММ за ПТ од 0,25 ги диференцираше КС од К со ДТ од 100%, 
и нозе/труп ММ количникот од 0,69 ги диференцираше КС од К со ДТ од 91,67%. Андроид/нозе 
ТМ (ПТ 0,27) и нозе/труп ТМ количниците (ПТ 0,62) ги диференцираа КС од КД со ДТ од 87,5%. 
Заклучок: Индексите андроид/нозе и нозе/труп ТМ и ММ ја откриваат екстремната централна 
дистрибуција на телесните маснотии кај КС, значaјно ги диференцираат КС од К и КД, и можат 
да бидат употребувани како ДХА индекси за екстремна централна абдоминална дебелина кај КС 
и не-КС здебелените жени. Андроид/нозе индексот има повисока ДТ и предиктивна вредност на 
екстремната висцерална дебелина кај КС, споредено со нозе/труп индексот.
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The aim of this study was to evaluate the central obesity, which is a main characteristic of Cushing‘s 
syndrome (CS), with dual-energy x-ray absorptiometry (DXA) and to determine DXA indexes that 
precisely differentiate CS from non CS obese women. In 12 CS women and 12 control obese (CO) 
with appropriate BMI which was not significantly different from CS, and 12 healthy control women 
(C) with normal BMI, the following DXA parameters were evaluated: regional (trunk, android and 
legs) tissue (TM) and fat mass (FM), and also the diagnostic accuracy (DG) for their ratio index cut-off 
points (CP). The best differentiation of CS from C obtained CP of 0.24 for android/legs TM ratio with 
DG of 100%, while CP for legs/trunk TM ratio (0.67) had DG of 95.83%. Android/legs FM ratio CP of 
0.25 differentiated CS from C for DG of 100% and legs/trunk FM ratio of 0.69 differentiated CS from 
C for DG of 91.67%. Android/legs TM ratio (CP 0.27) and legs/trunk ТМ ratio (CP 0.62) differentiated 
CS from CO with DG of 87.5%. Conclusion: DXA indexes android/legs and legs/trunk TM and FM 
discovered extreme central body fat distribution in CS, differentiated them significantly from C and 
CO, and could be used as DXA indexes of extreme central, abdominal obesity in CS and non CS obese 
women. Android/legs index had higher DG and predictive value of extreme visceral obesity in CS, 
compared to legs/trunk index.
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Introduction 
The core abnormality of CS is extreme 
central, visceral, abdominal obesity. 
Chronic hypercortisolemia due to Cush-
ing‘s disease (CD) results in abnormal 
adipose tissue distribution.1 Measure-
ments of body composition and body fat 
distribution have provided a research 
tool to study the metabolic effects of ag-
ing, obesity, and various diseases such 
as CS.2 Obesity and central body fat 
distribution are known risk factors for 
cardiovascular and metabolic diseases. 
Dual-energy X-ray absorptiometry (DXA) 
body composition and fat distribution 
assessment may be useful in studies re-
lated to obesity-associated disease risk.3 
DXA is a gold standard for assessment of 
bone health and body composition, be-
cause of its reliability, precision and the 
fact that it is based on a three-compart-
ment model.4 Published studies have 
shown a good correlation between cen-
tral abdominal fat by DXA and visceral 
fat by computed tomography or mag-
netic resonance imaging.5,6 DXA meth-
od determines absolute (kg) and relative 
(%) total, bone, lean and fat body mass 
and separately their regional values on 
arms, legs, head and trunk (includes 
ribs, pelvis, abdominal, thoracic and 
lumbar spine).7 Shubeska-Stratrova S. 
(2015), showed that the ratios of non-sig-
nificantly different central and periph-
eral regional parts of the body precisely 
differentiated patients with CS and non 
CS obese, and confirmed central body 
fat distribution in CS. Relationships be-
tween central regional tissue and fat 
mass to peripheral regional parts of the 
body in CS are needed as diagnostic DXA 
indexes of central obesity.8 
The aim of this study was to evaluate 
the central obesity with DXA indexes 
android/legs and legs/trunk tissue mass 
(TM) and fat mass (FM) and to determine 
their diagnostic accuracy and predictive 
value in precise differentiation of CS 
from non CS obese women
Material and Methods
This transversal study was organized 
and realized at the University Clinic of 
Endocrinology, Diabetes and Metabol-
ic Disorders, University „Ss Cyril and 
Methodius“, Medical Faculty in Skopje. 
Central obesity was evaluated in two 
groups of obese women. One group of 
obese women (N=12) had Cushing‘s syn-
drome (Cushing‘s syndrome group, CS), 
diagnosed with standard clinical ex-
aminations; hormonal and metabolic 
parameters; anthropometry; and du-
al-energy x-ray absorptiometry (DXA). 
The other group (N=12) comprised con-
trol obese women (CO) without Cush-
ing‘s syndrome or other clinical condi-
tion. These two groups were matched 
according to age and BMI, which mean 
values were 39.92 ± 12.62 y and 29.63 ± 
3.96 kg/m2 in CS, and 36.4 ± 13.72 y and 
29.56 ± 3.57 kg/m2 in CO. The results of 
CS and CO were compared with a group 
of healthy woman with normal BMI, 
assigned as a control healthy group 
(C) with mean age of 36.8 ± 12.09 y and 
mean BMI of 22.29 ± 1.37 kg/m2. All ex-
aminees were premenopausal. CS had 
not received any treatment at the time 
of assessment and had typical signs and 
symptoms of Cushing‘s syndrome in-
cluding extreme central obesity, which 
was discovered with anthropometry 
and DXA. All investigated women gave 
a personal permission to be included in 
this study and have been treated accord-
ing to the Declaration of Helsinki. 
DXA assessment was performed with 
DXA System Lunar DPX-NT, which uses 
enCore Windows-XP Professional OS 
computer. The entire body of each sub-
ject was scanned. During DXA scan, the 
subject was in a supine position while 
the x-ray scanner performed a series of 
transverse scans, measured at 1cm in-
tervals from the top of the head to the 
bottom of the toes. The DXA machine 
was calibrated daily in accordance with 
the manufacturer‘s guidelines to ensure 
adequate quality control. The following 
regional (segmental) DXA indicators 
were determined: trunk, android and 
legs tissue (TM) and fat mass (FM) in kg; 
and segmental ratios between central 
and peripheral parts of the body an-
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droid/legs (A/legs) and legs/trunk tissue 
and fat mass ratios. 
Statistical analysis was done with SPSS 
for Windows, version 14.0. Variables 
were presented as means ± standard de-
viations. Differences between the groups 
were tested by unpaired t-test and ANO-
VA was used to compare the measure-
ments with normal distribution. Level 
of significance was set at p < 0.05. Cut-
off point values were determined for all 
DXA indexes and their specificity, sensi-
tivity, positive and negative predictive 
value and diagnostic accuracy (DG) were 
evaluated in the following way:
• Sensitivity (true positive rate) is the 
probability that a test result – ex-
treme visceral obesity will be posi-
tive when the CS disease is present.
• Specificity (true negative rate) is the 
probability that a test result will be 
negative; there is no extreme central 
body fat distribution, when the dis-
ease is not present in C and CO.  
• Positive predictive value (PPV): the 
proportion of those with a positive 
test result (extreme central body fat 
distribution) who actually have a dis-
ease (CS). 
• Negative predictive value (NPV): the 
proportion of those with a negative test 
result (without extreme central obesity) 
who do not have a disease (C and CO). 
• Diagnostic accuracy (effectiveness) 
was expressed as a proportion of cor-
rectly classified subjects (true posi-
tive rate + true negative rate) among 
all subjects.  
Results 
Table 1.  Differences in regional tissue and fat mass in Cushing‘s and non Cushing‘s 
   obese women compared with healthy controls
   Variable (kg)     Investigated groups   Significance (p)
        CS1         CO                        C            CS/CO   CS/C    CO/C
Trunk tissue mass  39.12 ± 7.39 35.57 ± 6.24 26.8 ± 3.07 NS2  <0.001     0.001
Android tissue mass  6.67 ± 1.4 5.77 ± 1.39 3.83 ± 0.55 NS  <0.001   <0.001
Legs tissue mass 21.08 ± 5.68 24.58 ± 3.77 20.59 ± 2.4 0.048    NS     NS
Trunk fat mass 19.76 ± 4.96 16.39 ± 3.6 9.48 ± 2.33 0.037  <0.001   <0.001
Android fat mass 3.65 ± 1.00 2.85 ± 0.85 1.32 ± 0.40 0.018  <0.001   <0.001
Legs fat mass  9.82 ± 3.77 11.83 ± 2.54 8.5 ± 1.73 NS    NS   0.007
1 CS, obese women with Cushing’s syndrome; CO control obese women; C, control 
healthy women; 2NS,  not significant 
Differences in regional TM and FM be-
tween investigated groups are shown in 
Table 1. Trunk and android TM are not 
significantly higher in CS compared to 
CO. Trunk and android FM were high-
er in CS compared to CO with a very 
small significant difference (p=0.037 and 
p=0.018). Trunk and android TM and 
FM values in C were significantly lower 
compared to CS and CO (p<0.001).  
Legs lean mass (LM) and FM were esti-
mated separately. Mean value of legs LM 
in CS was 11.26 ± 2.10 kg and it was sig-
nificantly lower (p<0.042) compared to 
CO who had mean value of 12.76 ± 1.91 
kg. Mean value of legs LM in C was 12.09 
± 1.01 kg. Legs FM was not significantly dif-
ferent between CS and CO (p>0.05). Legs 
TM was lower in CS compared to CO with 
a small significant difference (p<0.048).
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Table 2.  Differences in tissue and fat mass ratios indexes in Cushing‘s and non Cushing‘s 
    obese women compared with healthy controls
Cut-off points of TM and FM ratio indexes 
and their DG are shown in Table 3. Cut-
off point value of 0.24 for android/legs TM 
ratio and 0.25 for android/legs FM ratio, 
differentiated the best CS and C for DG of 
100%. Cut-off point of legs/trunk (0.67) TM 
ratio had DG of 95.83% and legs/trunk FM 
ratio cut-off point (0.69) had DG of 91.67% 
in differentiation of CS from C.  CS and CO 
were differentiated the best for A/legs ratio 
TM cut-off point value of 0.27 and legs/
trunk TM ratio cut-off point value of 0.62 
with DG of 87.5%. Android/legs ratio FM 
cut-off point value of 0.26 differentiated 
CS and CO for DG of 83.3
Discussion
CS patients are characterized with 
extreme central, visceral body fat 
distribution.9 Android obesity in CS 
and in non-CS abdominal obese with 
the metabolic syndrome, which is 
predominantly visceral, intra-abdominal, 
is more predictive of adipose-related 
comorbidities than gynecoid obesity, 
Index tissue and fat  Investigated groups           Significance (p)
mass ratios             CS1             CO          C  CS/CO     CS/C    CO/C
Android/Legs TMR2 0.33 ± 0.05 0.23 ± 0.04 0.19 ± 0.03 <0.001      <0.001      0.01
Android/Legs FMR 0.40 ± 0.11 0.24 ± 0.06 0.15 ± 0.04 <0.001      <0.001     0.014
Legs/trunk TMR 0.53 ± 0.07 0.69 ± 0.08 0.77 ± 0.09 <0.001      <0.001     0.01
Legs/trunk FMR 0.49 ± 0.14 0.73 ± 0.13 0.92 ± 0.18 <0.001   <0.001      0.005
1CS, obese women with Cushing’s syndrome; CO control obese women; C, control 
healthy women;  2TMR, tissue mass ratio; FMR, fat mass ratio
Android/legs TM and FM ratios indexes 
were significantly higher in CS compared 
to CO and C (p<0.001). Legs/trunk TM 
and FM ratios indexes values were 
significantly lower in CS compared to CO 
and C (p<0.001). The results are shown in 
Table 2.
Table 3.  Cut-off points of tissue and fat mass ratio indexes that best differentiated 
  Cushing‘s, non Cushing‘s obese and healthy controls
Index  mass ratios        Cut-off point    S1 (%)     SP (%)     PPV (%)     NPV (%)      DG (%) 
Android/Legs (CS-C)2     TMR        0.24        100      100    100       100       100             
                                            FMR       0.25     100    100    100       100       100
Android/Legs (CS-CO)    TMR           0.27          91.67     83.33     84.62        90.91      87.5
                                           FMR        0.26     100    66.67    75      100        83.33
Legs/trunk (CS-C)            TMR           0.67           100        91.67      92.31       100          95.83   
                                           FMR         0.69     91.67    91.67     91.67      91.67       91.67
Legs/trunk (CS-CO)         TMR       0.62     91.67    83.33     84.62      90.91       87.5
                         FMR       0.65     83.33   75     76.92      81.82       79.17
1S, sensitivity; SP, specificity; PPV, positive predictive value; NPV, negative predic-
tive value; DG, diagnostic accuracy; 2CS, obese women with Cushing’s syndrome; 
CO control obese women; C, control healthy normal weight women; TMR, tissue 
mass ratio; FMR, fat mass ratio
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which has a relatively peripheral (gluteal) 
distribution. There is growing evidence 
that intra-abdominal adipose tissue, 
rather than total body fat, is a risk factor 
for metabolic conditions associated with 
obesity. For this reason, the evaluation 
of intra-abdominal adipose tissue is 
clinically important.10,11 Because of 
that, effective methods for assessing 
visceral fat are important to investigate 
its role for the increased health risks in 
obesity.12,13,14 There is an increased interest 
in the evaluation of various methods for 
assessment of body composition and fat 
distribution.
DXA provide useful information on fat 
and lean masses as single measurement 
in an individual, particularly with respect 
to limb lean mass. A recent study has 
suggested that central fat distribution 
measured with DXA is a useful marker 
of insulin sensitivity in healthy subjects, 
and that a simple measurement of total 
(visceral plus anterior and posterior 
subcutaneous fat) abdominal fat mass 
is highly predictive of health risks and 
may be as valuable as measuring intra-
abdominal fat depots.15,16 
DXA is a good alternative to CT for 
predicting abdominal fat in the elderly 
population.17 This method allows us to 
determine more accurately the degree of 
obesity of a particular patient as well as 
body fat distribution.2,4
DXA is used to quantify abdominal fat 
mass.18 Central abdominal fat measured 
by DXA includes the visceral fat at 
this region plus anterior and posterior 
subcutaneous fat, and it highly correlates 
with intra-abdominal (visceral) fat 
measured by CT or MRI.19-27 A strong 
correlation exists between DXA and CT 
values for total abdominal fat.17,22
Patients with CS had less than a twofold 
increase in subcutaneous fat and 
greater than a fivefold increase in intra-
abdominal fat compared with values in 
healthy subjects. These findings suggest 
that fat in different body compartments 
responds differently to disease processes 
and that DXA can be used to measure 
these changes.28,29
A reduction of the total adipose tissue 
volume and a redistribution of adipose 
tissue from visceral to peripheral depots 
were found by using a multiscan CT 
technique after normalization of the 
hypercortisolic state in women with CS.30
The  first  study concerning the measur- 
ements of body composition in CS using DXA 
and CT was published by Wajchenberg.31 
Patients with CS had no increase in total 
body fat or the trunk region, but had a 
higher intra-abdominal fat area compared 
to obese subjects.
The study of Schafroth showed on a 
subgroup of 12 CS patients that trunk 
fat mass was significantly elevated, 
compared to obese controls (19.2 kg vs. 
14.7 kg, p < 0.01), whereas total fat mass 
was not significantly increased.9 The 
results of our  study are very similar 
to the study of Schafroth. Trunk and 
android TM values were not significantly 
different between CS and CO, and trunk 
(19.76±4.96 kg) and android FM (16.39±3.6 
kg) values were higher in CS with a 
small significant difference (p=0.38 and 
p=0.018). Trunk and android TM and FM 
levels in C were significantly lower than 
CS and CO because of significantly lower 
BMI in C. These data indicate that these 
regional DXA measurements cannot be 
used as indicators of visceral obesity in 
CS as well as CO. 
Age and menopausal status have no 
influence on the differences in fat mass 
and its distribution between CS, CO and 
C, because evaluated women in this study 
were age matched and all of them are 
premenopausal.
The study of Burt et al. in 2006 concluded 
that FM was higher and LBM lower in CS 
patients. However, there was a greater 
abnormality of regional body composition 
in patients with CS who exhibited a lower 
limb lean mass and a greater truncal 
fat.32 Truncal fat represented a greater 
proportion of total FM in CS (52.5 ± 1.8% 
vs. 46.9 ± 1.3%, p = 0.014) than in normal 
subjects.32  The results of the Burth study 
were confirmed in this study in which legs 
FM was not different among CS and CO, 
but legs TM was lower in CS compared to 
CO with a small significant difference as 
a result of lower legs LM. 
In Jebb’s study Cushing disease 
patients had higher visceral versus 
total adipose tissue ratios, suggesting 
that glucocorticoids play a pivotal 
role in the pathogenesis of central 
obesity.1 
АРХИВИ НА ЈАВНОТО ЗДРАВЈЕ
23
This study represents continuation 
of the previous study of Shubeska-
Stratrova, which indicated the need of 
determination of cut-off point values for 
different DXA body segmental indexes 
in order to evaluate their diagnostic 
value. In the previous study, DXA indexes 
were presented by ratios of central to 
peripheral segmental parts of the body 
that best differentiated CS from C and 
CO. DXA indexes of central body fat 
distribution in CS also could be a gold 
standard, diagnostic criterion of extreme 
central, visceral obesity in C and CO (non 
CS).8
In this study it was found that android/
legs and legs/trunk TM and FM ratios 
differentiated CS and CO with very high 
significance (p<0.001) and discovered 
extreme central body fat distribution in 
CS.
Lower legs/trunk TM values differentiated 
better CS from CO than legs/trunk FM, 
because of lower legs LM in legs TM in CS 
compared to CO, and very low significant 
higher trunk FM in CS compared to CO 
(p<0.037). Therefore, legs/trunk TM ratio 
had higher DG (87.5%) than legs/trunk FM 
ratio (79.17%). 
Legs TM and FM were not significantly 
different between CS and C, but trunk 
and android TM and FM were significantly 
higher in CS than C (p<0.001). Therefore, 
android/trunk TM ratio differentiated 
CS and C with DG of 95.83% and android/
trunk FM ratio differentiated them for 
DG of 91.67%.    
Cut-off point value of 0.24 for android/
legs TM ratio and 0.25 for android/legs FM 
ratio differentiated the best CS and C for 
sensitivity, specificity, predictive value 
and DG of 100%. Legs/trunk TM ratio cut-
off point 0.67 differentiated CS and C for 
sensitivity of 100% and DG of 95.83%, and 
legs/trunk FM ratio cut-off point value of 
0.69 differentiated them for DG of 91.67%. 
Cut-off point value of 0.27 for android/
legs TM ratio, and 0.62 for legs/trunk TM 
ratio differentiated CS and CO for DG of 
87.5%. Android/legs FM ratio cut-off point 
value of 0.26 differentiated CS and CO 
for sensitivity of 100% and DG of 83.33%. 
Legs/trunk FM ratio cut-off point value 
of 0.65 had the lowest DG of 79.17% in 
differentiation of CS and CO. 
In medical diagnosis a perfect predictor 
described as 100% sensitive means that 
all individuals with CS are correctly 
identified as sick – with extreme visceral 
obesity. It is most important not to 
avoid individuals with extreme visceral 
obesity and to take care of them on time 
irrespective of the fact whether they 
are CS patients or metabolic syndrome 
patients with extreme visceral obesity.9
Conclusions 
DXA indexes android/legs and legs/trunk 
TM and FM ratios discovered extreme 
central body fat distribution in CS; 
differentiated them significantly from C 
and CO, and could be used as DXA indexes 
of extreme central, visceral, abdominal 
obesity in CS and non CS obese women. 
Android/legs index had higher DG and 
predictive value of extreme visceral 
obesity in CS and non CS than legs/trunk 
index. These data confirmed android/legs 
TM and FM ratio as a better DXA index of 
central obesity in CS and non CS obese, 
and also confirmed that central against 
peripheral parts of the body relations are 
better predictors of central, abdominal 
obesity in CS and CO.
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